Sean Duffy Sells 21,572 Shares of Omada Health (NASDAQ:OMDA) Stock

by · The Markets Daily

Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CEO Sean Duffy sold 21,572 shares of the company’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $23.62, for a total value of $509,530.64. Following the sale, the chief executive officer owned 411,861 shares in the company, valued at approximately $9,728,156.82. The trade was a 4.98% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Omada Health Stock Performance

Shares of OMDA stock opened at $22.77 on Friday. The company has a market cap of $1.39 billion, a P/E ratio of 455.40 and a beta of 1.86. The stock has a 50 day simple moving average of $22.70 and a two-hundred day simple moving average of $17.58. Omada Health, Inc. has a fifty-two week low of $10.28 and a fifty-two week high of $26.92.

Omada Health (NASDAQ:OMDA – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. The firm had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. Omada Health had a return on equity of 2.60% and a net margin of 1.39%. On average, research analysts predict that Omada Health, Inc. will post 0.09 earnings per share for the current year.

Hedge Funds Weigh In On Omada Health

A number of hedge funds and other institutional investors have recently modified their holdings of OMDA. Raymond James Financial Inc. purchased a new stake in shares of Omada Health during the second quarter valued at approximately $32,000. Bellevue Group AG boosted its position in Omada Health by 0.7% in the third quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock worth $5,567,000 after purchasing an additional 1,791 shares during the last quarter. Quarry LP bought a new position in Omada Health in the 4th quarter valued at $29,000. Barclays PLC grew its stake in Omada Health by 14.6% in the 4th quarter. Barclays PLC now owns 14,850 shares of the company’s stock valued at $234,000 after purchasing an additional 1,888 shares during the period. Finally, Versant Capital Management Inc increased its position in shares of Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after purchasing an additional 2,283 shares during the last quarter.

Analyst Upgrades and Downgrades

Several research firms have recently commented on OMDA. Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. JPMorgan Chase & Co. boosted their price objective on Omada Health from $26.00 to $30.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. Wells Fargo & Company raised their target price on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Barclays raised their price objective on Omada Health from $20.00 to $25.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $28.00 target price on shares of Omada Health in a research note on Friday, May 8th. Eleven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Omada Health has a consensus rating of “Moderate Buy” and an average price target of $26.50.

Check Out Our Latest Research Report on OMDA

Omada Health Company Profile

(Get Free Report)

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

Read More